A Comprehensive Guide to Hidradenitis Suppurativa

Despite being a relatively straightforward clinical diagnosis, recognition of hidradenitis suppurativa (HS) is highly variable, and clinical management is challenging and complex. Written by the world’s leading experts in HS, A Comprehensive Guide to Hidradenitis Suppurativa brings together up-to-date scientific evidence on the diagnosis, patho-mechanisms, comorbidities, and multi-faceted medical and surgical interventions for this debilitating condition-in one convenient reference. 

Table of Contents:

Front Matter and Preface

Section 1: Introduction to HS

1 Historic Perspectives

2 Epidemiology

3 Clinical Manifestations and Phenotypes

4 Differential Diagnosis

5 Histopathology

6 Imaging Modalities

7 Clinical Evaluation

8 Comorbidities and Systemic Associations

9 Disease Complications

Section 2: Pathogenesis

10 Follicular Occlusion and Inflammation

11 Microbiome

12 Genetics and Epigenetics

Section 3: Clinician's Corner

13 Management and Outcome Measure Guidelines

14 Topical Therapeutics

15 Systemic Antibiotics

16 Non-Antibiotic Systemic Therapeutics for HS

17 Targeted Therapeutics: Biologics, Small Molecules

18 Pain and Itch Control

19 Wound Care

20 Quality of Life

21 Office-Based Non-Excision Procedures

22 Office-Based Surgical Excision

23 OR-Based Surgical Procedures

24 Laser and Light-Based Treatments

25 Other Procedural Treatments

26 Lifestyle Modifications

27 Complementary and Alternative Medicine (CAM)

Section 4: Special Populations

28 Pediatrics

29 Skin of Color

30 Women of Childbearing Age

Section 5: Combined Approach

31 HS Action Plan

32 HS Multi-Disciplinary Approach

33 HS Support Groups

Section 6: On the Horizon

34 Pipeline Therapeutics

35 The Future

Index

Vivian Y. Shi, MD, Associate Professor, Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.; Jennifer L. Hsiao, MD, Assistant Clinical Professor of Dermatology, Director, Hidradenitis Suppurativa Specialty Clinic, University of California, Los Angeles, California; Michelle Lowes, MD, PhD, Associate Professor of Clinical Investigation, The Laboratory for Investigative Dermatology, Rockefeller University, New York, New York and Iltefat Hamzavi, MD, Henry Ford Hospital, Clinical Associate Professor, Department of Dermatology, Wayne State University SOM; President, HS Foundation, Detroit, Michigan